The role of angiogenic growth factors in organogenesis

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 365-375

  Crivellato, Enrico ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Angiogenic factor; Endothelial cell; Organ formation; Signalling pathway; Vasculogenesis

Indexed keywords

ANGIOGENIC GROWTH FACTOR; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; EPHRIN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; NETRIN; NOTCH RECEPTOR; SEMAPHORIN; SURVIVIN; TIE 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BONE GROWTH; BRANCHING MORPHOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HEART DEVELOPMENT; KIDNEY DEVELOPMENT; LIVER DEVELOPMENT; LUNG DEVELOPMENT; MOLECULAR MECHANICS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; ORGANOGENESIS; PANCREAS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANGIOGENIC PROTEINS; ANGIOPOIETINS; ANIMALS; BLOOD VESSELS; BONE DEVELOPMENT; ENDOTHELIAL CELLS; EPHRINS; FETAL HEART; FIBROBLAST GROWTH FACTORS; HUMANS; KIDNEY; LIVER; LUNG; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; ORGANOGENESIS; PANCREAS; RECEPTORS, NOTCH; SEMAPHORINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960989640     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103214ec     Document Type: Article

References (145)

1. ABRAHAMSON D.R., ROBERT B., HYINK D.P., ST JOHN P.L. and DANIEL T.O. (1998). Origins and formation of microvasculature in the developing kidney. Kidney Int. 54: S7-11.
2. AHLBRECHT K., SCHMITZ J., SEAY U., SCHWARZ C., MITTNACHT-KRAUS R., GAUMANN A., HABERBERGER R.V., HEROLD S., BREIER G., GRIMMINGER F., SEEGER W. and VOSWINCKEL R. (2008). Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. Am J Respir Cell Mol Biol 39: 163-170.
3. AKHURST R.J., LEHNERT S.A., FAISSNER A. and DUFFIE E. (1990). TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108: 645-656.
4. ALTIERI D.C. (2008). New wirings in the surviving networks. Oncogene 27: 6276-6284.
5. ALVA J.A. and IRUELA-ARISPE M.L. (2004). Notch signalling in vascular morphogenesis. Curr Opin Hematol 4: 278-283.
6. BAGRI A., and TESSIER-LAVIGNE M., (2002). Neuropilins as Semaphorin receptors: in vivo functions in neural cell migration and axon guidance. Adv Exp Med Biol 515: 13-31.
7. BARON J., KLEIN K.O., YANOVSKI J.A., NOVOSAD J.A., BACHER J.D., BOLANDER M.E. and CUTLER G.B. JR. (1994). Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology 135: 2790-2793.
8. BATES D., TAYLOR G.I., MINICHIELLO J., FARLIE P., CICHOWITZ A., WATSON N., KLAGSBRUN M., MAMLUK R. AND NEWGREEN D.F. (2002). Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol 255: 77-98.
9. BETSHOLTZ C., KARLSSON L. and LINDAHL P. (2001). Developmental roles of platelet-derived growth factors. Bioessays 23: 494-507.
10. BJARNEGÅRD M., ENGE M., NORLIN J., GUSTAFSDOTTIR S., FREDRIKSSON S., ABRAMSSON A., TAKEMOTO M., GUSTAFSSON E., FÄSSLER R. and BETSHOLTZ C. (2004) Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131: 1847-1857.
11. BOULETREAU P.J., WARREN S.M., SPECTOR J.A., PELED Z.M., GERRETS R.P., GREENWALD J.A. and LONGAKER M.T. (2002). Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109: 2384-2397.
12. BURRI P.H. (1984). Fetal and postnatal development of the lung. Ann Rev Physiol 46: 617-628.
13. CARLEVARO M.F., ALBINI A., RIBATTI D., GENTILI C., BENELLI R., CERMELLI S., CANCEDDA R. and CANCEDDA F.D. (1997). Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol 136: 1375-1384.
14. CARLEVARO M.F., CERVELLI S., CANCEDDA R. and DESCALZI CANCEDDA F. (2000). Vascular endothelia growth factor (VEGF) in chartilage neovascularization and chondrocyte differentiation: auto paracrine-role during endochondral bone formation. J Cell Sci 113: 59-69.
15. CARMELIET P. (2003). Angiogenesis in health and disease. Nat Med 9: 653-660.
16. CARMELIET P. (2005). Angiogenesis in life, disease and medicine. Nature 438: 932-936.
17. CARMELIET P. and TESSIER-LAVIGNE M. (2005). Common mechanisms of nerve and blood vessel wiring. Nature 436: 193-200.
18. CHOI M.E. and BALLERMANN B.J. (1995). Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J Biol Chem 270: 21144-21150.
19. CLEAVER O. and MELTON D.A. (2003) Endothelial signalling during development. Nat Med 9: 661-668.
20. COMPERNOLLE V., BRUSSELMANS K., ACKER T., HOET P., TJWA M., BECK H., PLAISANCE S., DOR Y., KESHET E., LUPU F., NEMERY B., DEWERCHIN M., VAN VELDHOVEN P., PLATE K., MOONS L., COLLEN D. and CARMELIET P. (2002). Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fetal respiratory distress in premature mice. Nat Med 8: 702-710.
21. COULTAS L., CHAWENGSAKSOPHAK K. and ROSSANT J. (2005). Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
22. COX C.M., and POOLE T.J. (2000). Angioblast differentiation is influenced by the local environment: FGF-2 induces angioblasts and pattern vessel formation in the quail embryo. Dev Dyn 218: 371-382.
23. DARLAND D.C. and D'amore P.A. (2001). Cell-cell interactions in vascular development. Curr Top Dev Biol 52: 107-149.
24. DAVIS S. and YANCOPOULOS G.F. (1999). The angiopoietins: yin and yang in angiogenesis. Curr Top Microbiol Immunol 273:173-185.
25. DEL MORAL P.M., SALA F.G., TEFFT D., SHI W., KESHET E., BELLUSCI S. and WARBURTON D. (2006). VEGF-A signalling through Flk-1 is a critical facilitator of early embryonic lung epithelial to endothelial crosstalk and branching morphogenesis. Dev Biol 290: 177-188.
26. DELVAEYE M., DE VRIESE A., ZWERTS F., BETZ I., MOONS M., AUTIERO M. and CONWAY E.M. (2009). Role of the two zebrafish survivin genes in vasculo-angiogenesis, neurogenesis, cardiogenesis and haematopoiesis. BMC Dev Biol 9: 25.
27. DE MELLO D.E., SAWYER D., GALVIN N. and REID L.M. (1997). Early fetal development of lung vasculature. Am J Resp Cell Mol Biol 16: 568-581.
28. DICKSON B.J. (2002). Molecular mechanisms of axon guidance. Science 298: 1959-1964.
29. DÜNKER N. and KRIEGLSTEIN K. (2000). Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem 267: 6982-6988.
30. DU PASQUIER D., PHUNG A.C., YMLAHI-OUAZZANI Q., SINZELLE L., BALLAGNY C., BRONCHAIN O., DU PASQUIER L. and MAZABRAUD A. (2006). Survivin increases vascular development during Xenopus ontogenesis. Differentiation 74: 344-253.
31. DUMONT D.J., GRADWOHL G., FONG G.H., PURI M.C., GERTSENSTEIN M., AUERBACH A., and BREITMAN M.L., (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 15: 1897-1909.
32. EDSBAGGE J., JOHANSSON J.K., ESNI F., LUO Y., RADICE G.L. and SEMB H. (2005). Vascular function and sphingosine-1-phosphate regulate development of the dorsal pancreatic mesenchyme. Development 132: 1085-1092.
33. EREMINA V., SOOD M., HAIGH J., NAGY A., LAJOIE G., FERRARA N., GERBER H.P., KIKKAWA Y., MINER J.H. and QUAGGIN S.E. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716.
34. EREMINA V. and QUAGGIN S.E. (2004). The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15.
35. ESNI F., JOHANSSON B., RADICE G.L. and SEMB H. (2001). Dorsal pancreas agenesis in N-cadherin-deficient mice. Dev Biol 238: 202-212.
36. FERRARA N., GERBER H.P. and LECOUTER J. (2003). The biology of VEGF and its receptors. Nat Med 9: 669-676.
37. FIEDLER J., LEUCHT F., WALTENBERGER J., DEHIO C. and BRENNER R.E. (2005). VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334: 561-568.
38. FIEDLER J., BRILL C., BLUM W.F. and BRENNER R.E. (2006) IGF-I and IGF-II stimulate direct cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345: 1177-1183.
39. FIEDLER U., SCHARPFENECKER M., KOIDL S., HEGEN A., GRUNOW V., SCHMIDT J.M., KRIZ W., THURSTON G. and AUGUSTIN H.G. (2004). The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103: 4150-4156.
40. FLAMME I., FROLICH T., and RISAU W. (1997). Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173: 206-210.
41. FUKUSHI J., MAKAGIANSAR I.T. and STALLCUP W.B. (2004). NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha 3 beta 1 integrin. Mol Biol Cell 15: 3580-3590.
42. GARRATT A.N. (2006). ''To erb-B or not to erb-B...'' Neuregulin-1/ErbB signalling in heart development and function. J Mol Cell Cardiol 41: 215-218.
43. GARRATT A.N., OZCELIK C. and BIRCHMEIER C. (2003). ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med 13: 80-86.
44. GERBER H.P. and FERRARA N. (2000). Angiogenesis and bone growth. Trends Cardiovasc Med 10: 223-228.
45. GERBER H.P., HILLAN K.J., RYAN A.M., KOWALSKI J., KELLER G.A., RANGELL L., WRIGHT B.D., RADTKE F., AGUET M. and FERRARA N. (1999a). VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159.
46. GERBER H.P., VU T.H., RYAN A.M., KOWALSKI J., WERB Z. and FERRARA N. (1999b). VEGF couples hypertrophic chartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
47. GERETY S.S., WANG H.U., CHEN Z.F. and ABDERSON D.J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand sphrin-B2 in cardiovascular development. Mol Cell 4: 403-414.
48. GERHARDT H., GOLDING M., FRUTTIGER M., RUHRBERG C., LUNDKVIST A., ABRAMSSON A., JELTSCH M., MITCHELL C., ALITALO K., SHIMA D. and BETSHOLTZ C. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell philopodia. J Cell Biol 161: 1163-1177.
49. GERHARDT H. (2008). VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4: 241-246.
50. GLEBOVA N.O. and GINTY D.D. (2005). Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 28: 191-222.
51. GOUYSSE G., COUVELARD A., FRACHON S., BOUVIER R., NEJJARI M., DAUGE M.C., FELDMANN G., HÉNIN D. and SCOAZEC J.Y. (2002). Relationship between vascular development and vascular differentiation during liver organogenesis in humans. J Hepatol 37: 730-740.
52. GRELLIER M., BORDENAVE L. and AMEDEE J. (2009a). Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27: 562-571.
53. GRELLIER M., GRANJA P.L., FRICAIN J.C., BIDARRA S.J., RENARD M., BAREILLE R., BOURGET C., AMÉDÉE J. and BARBOSA M.A. (2009b). The effect of co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30: 3271-3278.
54. GUALDI R., BOSSARD P., ZHENG M., HAMADA Y., COLEMAN J.R. and ZARET K.S. (1996) Hepatic specification of the gut endoderm in vitro: cell signalling and transcriptional control. Genes Dev 10: 1670-1682.
55. GUIDOLIN D., CRIVELLATO E. and RIBATTI D. (2011). The ''self-similarity'' logic applied to the development of the vascular system. Dev Biol 351: 156-162.
56. HALLENE K.L., OBY E., LEE B.J., SANTAGUIDA S., BASSANINI S., CIPOLLA M., MARCHI N., HOSSAIN M., ÄBATTAGLIA G. and JANIGRO D. (2006). Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations. Neuroscience 142: 267-283.
57. HELBLING P.M., SAULNIER D.M. and BRANDLI A.W. (2000). The receptor tyrosine kinase EphB4 and ephrin-B ligand restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 127: 269-278.
58. HONMA Y., ARAKI T., GIANINO S., BRUCE A., HEUCKEROTH R., JOHNSON E. and MILBRANDT J. (2002). Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron 35: 267-282.
59. HORNER A., BISHOP N.J., BORD S., BEETON C., KELSALL A.W., COLEMAN N. and COMPSTON J.E. (1999). Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 194: 519-524.
60. ICARDO J.M. (1989). Changes in endocardial cell morphology during development of endocardial cushion. Anat Embryol 179: 443-448.
61. JACQUEMIN P., LEMAIGRE F.P. and ROUSSEAU G.G. (2003). The Onecut transcription factor HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream of Pdx-1 in the specification cascade. Dev Biol 258: 105-116.
62. JACQUEMIN P., YOSHITOMI H., KASHIMA Y., ROUSSEAU G.G., LEMAIGRE F.P. and ZARET K.S. (2006) An endothelial-mesenchymal relay pathway regulates early phases of pancreas development. Dev Biol 290: 189-199.
63. JIANG Y., DE BRUIN A., CALDAS H., FANGUSARO J., HAYES J., CONWAY E.M., ROBINSON M. and ALTURA R.A. (2005). Essential role for survivin in early brain development. J Neurosci 25: 6962-6970.
64. JUNG J., ZHENG M., GOLDFARB M. and ZARET K. (1999). Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284: 1998-2003.
65. KARKKAINEN M.J., HAIKO P., SAINIO K., PARTANEN J., TAIPALE J., PETROVA T.V., JELTSCH M., JACKSON D.G., TALIKKA M., RAUVALA H., BETSHOLTZ C. and ALITALO K. (2004). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80.
66. KAWASAKI T., KITSUKAWA T., BEKKU Y., MATSUDA Y., SANBO M., YAGI T., FUJISAWA H. (1999). A requirement for neuropilin-1 in embryonic vessel formation. Development 126: 4895-4902.
67. KESSLER O., SHRAGA-HELED N., LANGE T., GUTMANN-RAVIV N., SABO E., BARUCH L., MACHLUF M. and NEUFELD G. (2004). Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 64: 1008-1015.
68. KITAMOTO Y., TOKUNAGA H. and TOMITA K. (1997). Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357.
69. KUMAR M., JORDAN N., MELTON D. and GRAPIN-BOTTON A. (2003). Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev Biol 259: 109-122.
70. KURUVILLA R., ZWEIFEL L.S., GLEBOVA N.O., LONZE B.E., VALDEZ G., YE H. and GINTY D.D. (2004). A neurotropin signalling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signalling. Cell 118: 243-255.
71. LAMMERT E., CLEAVER O. and MELTON D. (2001). Induction of pancreatic differentiation by signals from blood vessels. Science 294: 564-567.
72. LAMMERT E., CLEAVER O. and MELTON D. (2003). Role of endothelial cells in early pancreas and liver development. Mech Dev 120: 59-64.
73. LARRIVÉE B., FREITAS C., SUCHTING S., BRUNET I. and EICHMANN A. (2009). Guidance of vascular development. Lessons from the nervous system. Circ Res 104: 428-441.
74. LEBRIN F., DECKERS M., BERTOLINO P. and TEN DIJKE P. (2005). TGF-beta receptor function in the endothelium. Cardiovasc Res 65: 599-608.
75. LECOUTER J., MORITZ D.R., LI B., PHILLIPS G.L., LIANG X.H., GERBER H.P., HILLAN K.J. and FERRARA N. (2003). Angiogenesis-independent endothelial protection of liver: role of VEGFR1. Science 299: 890-893.
76. LEMKE G. (1996). Neuregulins in development. Mol Cell Neurosci 7: 247-262.
77. LEUNG C.G., XU Y., MULARSKI B., LIU H., GURBUXANI S. and CRISPINO J.D. (2007). Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med 204: 1603-1611.
78. LI D.Y., SORENSEN L.K., BROOKE B.S., URNESS L.D., DAVIS E.C., TAYLOR D.G., BOAK B.B. and WENDEL D.P. (1999). Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
79. LIANG D., CHANG J.R., CHIN A.J., SMITH A., KELLY C., WEINBERG E.S. and GE R. (2001). The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and haematopoiesis in zebrafish development. Mech Dev 108: 29-43.
80. LU X., LE NOBLE F., YUAN L., JIANG Q., DE LAFARGE B., SUGIYAMA D., BRÉANT C., CLAES F., ÄDE SMET F., THOMAS J.L., AUTIERO M., CARMELIET P., TESSIER-LAVIGNE M. and EICHMANN A. (2004). The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432: 179-186.
81. MA A., LIN R., CHAN P.K., LEUNG J.C., CHAN L.Y., MENG A., VERFAILLIE C.M., LIANG R. and LEUNG A.Y. (2007). The role of survivin in angiogenesis during zebrafish embryonic development. BMC Dev Biol 7: 50.
82. MAES C., CARMELIET P., MOERMANS K., STOCKMANS I., SMETS N., COLLEN D., BOUILLON R. and CARMELIET G. (2002). Impaired angiogenesis and endochondral bone formation in mice lacking the vescular endothelial growth factor isoforms Vegf164 and Vegf188. Mech Dev 111: 61-73.
83. MAISONPIERRE P.C., SURI C., JONES P.F., BARTUNKOVA S., WIEGAND S.J., RADZIEJEWSKI C., COMPTON D., MCCLAIN J., ALDRICH T.H., PAPADOPOULOS N., DALY T.J., DAVIS S., SATO T.N. and YANCOPOULOS G.D. (1997). Angiopoietin-2, a natural antagonist for Tie 2 that disrupts in vivo angiogenesis. Science 277: 55-60.
84. MAKINEN T., ADAMS R.H., BAILEY J., LU Q., ZIEMIECKI A., ALITALO K., KLEIN R. and WILKINSON G.A. (2005). PDZ interaction site in ephrinB2 is required for the remodelling of the lymphatic vasculature. Genes & Dev 19: 397-410.
85. MAKITA T., SUCOV H.M., GARIEPY C.E., YANAGISAWA M. and GINTY D.D. (2008). Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons. Nature 452: 759-763.
86. MAJUMDAR A. and DRUMMOND L.A. (1999) Podocyte differentiation in the absence of endothelial cells as revealed in the zebrafish avascular mutant, cloche. Dev Genet 24: 220-229.
87. MARKWALD R., EISENBERG L., EISENBERG C. and SUGI Y. (1996). Epithelial-mesenchymal transformations in early avian heart development. Acta Anat 156: 173-186.
88. MASSAGUE J. (1998). TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
89. MATSUMOTO K., YOSHITOMI H., ROSSANT J. and ZARET K.S. (2001). Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294: 559-563.
90. MAYR-WOHLFART U., WALTENBERGER J., HAUSSER H., KESSLER S., GUNTHER K.P., DEHIO C., PUHL W. and BRENNER R.E. (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472-477.
91. MEYER D., YAMAAI T., GARRATT A., RIETHMACHER-SONNENBERG E., KANE D., THEILL L.E. and BIRCHMEIER C. (1997). Isoform-specific expression and function of neuregulin. Development 124: 3575-3586.
92. METZGER R.J., KLEIN O.D., MARTIN G.R. and KRASNOW M.A. (2008). The branching programme of mouse lung development. Nature 453: 745-751.
93. MIAO H.Q., SOKER S., FEINER L., ALONSO J.L., RAPER J.A. and KLAGFBRUN M. (1999). Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility. Functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146: 233-242.
94. MILAN D.J., GIOKAS A.C., SERLUCA F.C., PETERSON R.T. and MACRAE C.A. (2006). Notch 1b and neuregulin are required for specification of central cardiac conduction tissue. Development 133: 1125-1132.
95. MUKOUYAMA Y.S., SHIN D., BRITSCH S., TANIGUCHI M. and ANDERSON D.J. (2002). Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109: 693-705.
96. NAGY J.A., DVORAK A.M. and DVORAK H.F. (2003). VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med 13: 169-175.
97. NAKAJIMA Y., KRUG E.L. and MARKWALD R.R. (1994). Myocardial regulation of transforming growth factor-beta expression by out-flow tract endothelium in the early embryonic chick heart. Dev Biol 165: 615-626.
98. NG Y.S., ROHAN R., SUNDAY M.E., DE MELLO D.E. and D'amore P.A. (2001). Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220: 112-121.
99. OTOMO H., SAKAI A., UCHIDA S., TANAKA S., WATANUKI M., MORIWAKI S., NIIDA S. and NAKAMURA T. (2007). Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40: 1494-1501.
100. OZERDEM U. and STALLCUP W.B. (2004). Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 7: 269-276.
101. PALMER T.D., WILLHOITE A.R. and GAGE F.H. (2000). Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425: 479-494.
102. PATAN S. (1998). TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 56: 1-2.
103. PEREZ-POMARES J.M., CARMONA R., GONZALEZ-IRIARTE M., MACIAS D., GUADIX J.A. and MUNOZ-CHAPULI R. (2004). Contribution of mesothelium-derived cells to liver sinusoids in avian embryos. Dev Dyn 229: 465-474.
104. PRESTA M., Dellera P., MITOLA S., MORONI E., RONCA R. and RUSNATI M. (2005). Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178.
105. PUGH C.W. and RATCLIFFE P.J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
106. RAMSDELL A.F. and MARKWALD R.R. (1997). Induction of endocardial cushion tissuein the avian heart is regulated, in part, by TGF-β-3-mediated autocrine signalling. Dev Biol 188: 64-74.
107. RAOUL W., CHAILLEY-HEU B., BARLIER-MUR A.M., DELACOURT C., MAITRE B. and BOURBON J.R. (2004). Effects of vascular endothelial growth factor on isolated fetal alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 286: L1293-L1301.
108. RAPER J.A. (2000). Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10: 88-94.
109. RIBATTI D. (2006). Genetic and epigenetic mechanisms in the early development of the vascular system. J Anat 208: 139-152.
110. RISAU W. (1995). Differentiation of the endothelium. FASEB J 9: 926-933.
111. ROSENSTEIN J.M. and KRUM J.M. (2004). New roles for VEGF in nervous tissue - beyond blood vessels. Exp Neurol 187: 246-253.
112. ROSSI J.M., DUNN N.R., HOGAN B.L. and ZARET K.S. (2001). Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 15: 1998-2009.
113. RUHRBERG C., GERHARDT H., GOLDING M., WATSON R., IOANNIDOU S., FUJISAWA H., BETSHOLTZ C. and SHIMA D.T. (2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16: 2684-2698.
114. SAHARINEN P., TAMMELA T., KARKKAINEN M.J. and ALITALO K. (2004). Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387-395.
115. SAHARINEN P., EKLUND L., MIETTINEN J., WIRKKALA R., ANISIMOV A., WINDERLICH M., NOTTEBAUM A., VESTWEBER D., DEUTSCH U., KOH G.Y., OLSEN B.R. and ALITALO K. (2008). Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
116. SATO T.N., TOZAWA Y., DEUTSCH U.,WOLBURG-BUCHHOLZ K., FUJIWARA Y., GENDRON-MAGUIRE M., GRIDLEY T., WOLBURG H., RISAU W. and QIN Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
117. SCHANZER A., WACHS F.P., WILHELM D., ACKER T., COOPER-KUHN C., BECK H., WINKLER J., AIGNER L., PLATE K.H. and KUHN H.G. (2004). Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14: 237-248.
118. SCHNEIDER C., WICHT H., ENDERICH E., WEGNER M. and ROHRER H. (1999). Bone morphogenic proteins are required in vivo fort he generation of sympathetic neurons. Neuron 24: 861-870.
119. SERINI G., VALDEMBRI D., ZANIVAN S., MORTERRA G., BURKHARDT C., CACCAVARI F., ZAMMATARO L., PRIMO L., TAMAGNONE L., LOGAN M., TESSIER-LAVIGNE M., TANIGUCHI M., PÜSCHEL A.W. and BUSSOLINO F. (2003). Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424: 391-397.
120. SHALABY F., ROSSANT J., YAMAGUCHI T.P., GERTSENSTEIN M., WU X.F., BREITMAN M.L. and SCHUH A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
121. SHEN Q., GODERIE S.K., JIN L., KARANTH N., SUN Y., ABRAMOVA N., VINCENT P., PUMIGLIA K. and TEMPLE S. (2004). Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340.
122. SILVESTRE J.S., TAMARAT R., EBRAHIMIAN T.G., LE-ROUX A., CLERGUE M., EMMANUEL F., DURIEZ M., SCHWARTZ B., BRANELLEC D. and LÉVY B.I. (2003). Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 93: 114-123
123. STALMANS I. (2005). Role of the vascular endothelia growth factor isoforms in retinal angiogenesis and DiGeorge syndrome. Verh K Acad Geneeskd Belg 67: 229-276.
124. SUCHTING S., BICKNELL R. and EICHMANN A. (2006). Neuronal clues to vascular guidance. Exp Cell Res 312: 668-675.
125. SUGY Y. and MARKWALD R.R. (1996). Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol 175: 66-83.
126. SUNDBERG C., KOWANETZ M., BROWN L.F., DETMAR M. and DVORAK H.F. (2002). Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 82: 387-401.
127. TAMMELA T., ENHOLM B., ALITALO K. and PAAVONEN K. (2005). The biology of vascular endothelial growth factors. Cardiovas Res 65: 550-563.
128. THURSTON G. (2003). Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lynphangiogenesis. Cell Tissue Res 314: 61-68.
129. THURSTON G., SURI C., SMITH K., McClain J., SATO T.N., YANCOPOULOS G.D. and MC DONALD D.M. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.
130. TUFRO A., NORWOOD V.F., CAREY R.M. and GOMEZ R.A. (1999). Vascular endothelial growth factor induces nephrogenasis and vasculogenesis. J Am Soc Nephrol 10: 2125-2134.
131. VEILLETTE C.J. and von SCHROEDER H.P. (2004). Endothelin-1 down-regulates the expression of vascular endothelial growth factor-A associated with osteoprogenitor proliferation and differentiation. Bone 34: 288-296.
132. UEMURA A., OGAWA M., HIRASHIMA M., FUJIWARA T., KOYAMA S., TAKAGI H., HONDA Y., WIEGAND S.J., YANCOPOULOS G.D. and NISHIKAWA S. (2002). Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 110: 1615-1817.
133. VU T.H., SHIPLEY J.M., BERGERS G., BERGER J.E., HELMS J.A., HANAHAN D., SHAPIRO S.D., SENIOR R.M. and WERB Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
134. WAN M. and CAO X. (2005). BMP signalling in skeletal development. Biochem Biophys Res Commun 328: 651-657.
135. WANG H.U., CHEN Z.F. and ANDERSON D.J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753.
136. WANG T., BARON M. and TRUMP D. (2007). An overview of Notch 3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 96: 499-509
137. WELLS J.M. and MELTON D.A. (1999). Vertebrate endoderm development. Annu Rev Cell Dev Biol 15: 393-410.
138. YONEKURA H., SAKURAI S., LIU X., MIGITA H., WANG H., YAMAGISHI S., NOMURA M., ABEDIN M.J., UNOKI H., YAMAMOTO Y. and YAMAMOTO H. (1999). Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem 274: 35172-35178.
139. YOSHITOMI H. and ZARET K.S. (2004). Endothelial cell interactions initiate dorsal pancreas development by selectively inducing the transcription factor Ptf1a. Development 131: 807-817.
140. YUAN L., MOYON D., PANDANAUD L., BREANT C., KAKKAINEN M.J., ALITALO K. and EICHMANN A. (2002). Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129: 4797-4806.
141. ZELZER E., MCLEAN W., NG Y.S., FUKAI N., REGINATO A.M., LOVEJOY S., D'amore P.A. and OLSEN B.R. (2002). Skeletal defects in Vegf120/120 mice reveal multiple roles for Vegf in skeletogenesis. Development 129: 1893-1904.
142. ZELZER E., MAMLUK R., FERRARA N., JOHNSON R.S., SCHIPANI E. and OLSEN BR (2003) VEGFA is necessary for chondrocyte survival during bone development. Development 131: 2161-2171.
143. ZENG X., WERT S.E., FEDERICI R., PETERS K.G. and WHITSETT J.A. (1998). VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 211: 215-227.
144. ZHAO R. and DUNCAN S.A. (2005). Embryonic development of the liver. Hepatology 41: 956-967.
145. ZWERTS F., LUPU F., DE VRIESE A., POLLEFEYT S., MOONS L., ALTURA R.A., JIANG Y., MAXWELL P.H., HILL P., OH H., RIEKER C., COLLEN D., CONWAY SJ. and CONWAY E.M. (2007). Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood 109: 4742-4752.